Related Experiment Video

Updated: Feb 5, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

2.9K

Clinical effect of sequential therapy with azithromycin in children mycoplasma pneumoniae pneumonia

Jianlong Wang1, Cun Yang1

  • 1Pediatric Intensive Care Unit, Jining No.1, Pepole's Hospital, Jining, China.

Pakistan Journal of Pharmaceutical Sciences
|September 12, 2018
PubMed

Insights

Sequential therapy with azithromycin offers significant advantages for treating pediatric Mycoplasma pneumoniae pneumonia, improving recovery times and overall efficiency without increasing adverse reactions.

Area of Science:

  • Pediatric Infectious Diseases
  • Respiratory Medicine
  • Pharmacology

Background:

  • Mycoplasma pneumoniae pneumonia is a common respiratory infection in children.
  • Effective treatment strategies are crucial for improving patient outcomes and reducing healthcare burdens.

Purpose of the Study:

  • To evaluate the clinical efficacy and safety of sequential therapy with azithromycin in children diagnosed with Mycoplasma pneumoniae pneumonia.
  • To compare sequential azithromycin therapy with sequential erythromycin therapy.

Main Methods:

  • A randomized controlled study involving 160 children with Mycoplasma pneumoniae pneumonia.
  • Participants were divided into two groups: a study group receiving sequential azithromycin therapy and a reference group receiving sequential erythromycin therapy.
  • Key outcomes measured included overall treatment efficiency, symptom recovery time, hospitalization duration, and incidence of adverse reactions.

Main Results:

  • The study group (sequential azithromycin) demonstrated significantly higher overall treatment efficiency compared to the reference group (P<0.05).
  • Children in the study group experienced significantly shorter symptom recovery and hospitalization times (P<0.05).
  • No significant difference in the incidence of adverse reactions was observed between the two groups (P>0.05).

Conclusions:

  • Sequential therapy with azithromycin is an effective treatment for pediatric Mycoplasma pneumoniae pneumonia.
  • Azithromycin therapy shows significant clinical advantages, including improved efficacy and faster recovery, with a comparable safety profile to erythromycin.
  • The findings suggest substantial clinical applicability for sequential azithromycin therapy in this pediatric population.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.2K
Experimental Model to Evaluate Resolution of Pneumonia09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.9K

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
900
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
822
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.6K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
875
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K